Editorials in 2010

Filter By:

Article Type
Year

  • The integrity of climate research has taken a very public battering in recent months. Scientists must now emphasize the science, while acknowledging that they are in a street fight.

    Editorial

  • International university rankings need to be improved — and interpreted more wisely.

    Editorial

  • Young scientists at a Chinese genomics institute are foregoing conventional postgraduate training for the chance to be part of major scientific initiatives. Is this the way of the future?

    Editorial

  • General science meetings are good opportunities for researchers to broaden their horizons.

    Editorial

  • The new European research commissioner deserves political support from member states of the European Union to drastically reduce the dead weight of Brussels bureaucracy.

    Editorial

  • Industry talent should be welcomed into academia, not seen as a corrupting influence.

    Editorial

  • Turkey's government is about to pass legislation that could cripple the country's biological research.

    Editorial

  • Exploding the myths surrounding how and why we select our research papers.

    Editorial

  • Transparency and quality control are essential in the highly uncertain business of assessing the impact of climate change on a regional scale.

    Editorial

  • It is time to abandon GDP as the overriding measure of social development and economic health.

    Editorial

  • The time is ripe for Europe's scientists to lobby for community-wide infrastructure funding.

    Editorial

  • The nation's science enterprise still carries the scars of apartheid. But with reform — and increased funding — South Africa could become a catalyst for scientific progress throughout Africa.

    Editorial

  • NASA is taking a risk on commercial space services. But the pay-offs could be high.

    Editorial

  • The complexity of genetic regulation is one of the great wonders of nature, but it represents a daunting challenge to unravel. The International Human Epigenome Consortium is an appropriate response.

    Editorial

  • Researchers should be recognized for writing books to convey and develop science.

    Editorial

  • Science has done well in the proposed US budget. Researchers need to justify the funding boost.

    Editorial

  • The reporting of candidate biomarkers for disease must be rigorous to drive translational research.

    Editorial

  • By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow.

    Editorial

    • Deepa Nath
    • Ritu Dhand
    • Angela K. Eggleston
    Editorial